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Events which occur early in reproductive life, such as exposure to ionising radiation or an early menarche, are known to be related to the subsequent development of malignant neoplasms of the breast (Land et al., 1980 , MacMahon et al., 1973 . The breast may be susceptable during this period because of a high rate of cellular proliferation and because carcinogenic agents may act preferentially upon proliferating tissues (Russo et al., , 1987 . However there are few data concerning the association between age and proliferative activity of the normal human breast (Anderson et al., 1982 , Meyer, 1977 Russo et al., 1987) and one aim of this study was to investigate this relationship further.
Oestrogen is a major growth promoting hormone of the breast: under some circumstances progesterone acts as an antioestrogen and appears to inhibit proliferation (MauvaisJarvis et al., 1986) . On the basis of these observations Korenman (1980) proposed that the risk of breast cancer was related to a defective luteal phase with low or absent progesterone secretion. Women with anovular cycles would therefore be at high risk because of the unopposed action of oestrogen. In order to account for the increased risk associated with an early menarche he proposed that early cycles were likely to be anovular.
If progesterone was acting as an antioestrogen the proliferation of mammary epithelium during the luteal phase of the cycle would be expected to be lower than in the follicular phase. A study by Vogel et al. (1981) reported, without quantitative details, that mitotic activity was indeed hig-hest during the follicular phase; however other reports, on relatively small numbers of patients, suggest that proliferative activity is maximal during the luteal phase (Meyer, 1977; Masters et al., 1977; Ferguson & Anderson, 1981a; Longacre & Bartow, 1986; Going et al., 1988) . A second aim of this study was to determine the proliferative activity of the normal human breast in relation to the day of the menstrual cycle in order to resolve these conflicting data.
One feature of all studies on human breast is the consider-able variabiliy from sample to sample. The full explanation for this variability remains unclear but its existence indicates that much data must be accumulated by many groups before a complete understanding of the proliferative behaviour of the breast is achieved.
In an attempt to study as normal tissue as possible we have used biopsy material removed either away from the site of a fibroadenoma or from reduction mammoplasties. Here we present data on the labelling index, mitotic index and apoptotic index of the normal breast and show that these indices of proliferation decline with age and are higher during the second half of the menstrual cycle.
Materials and methods

Patient selection
Patients attending the breast clinic at the University Hospital of South Manchester were selected if, clinically, they had solitary benign lesions or if they were undergoing reduction mammoplasty. Each patient was interviewed on the day before, or the day of, operation. The purpose and nature of the research was explained and verbal consent obtained. Details of the history and clinical features for each patient were recorded. These included parity, stage of menstrual cycle, age and whether or not oral contraceptives had been used recently or at any time in the past.
Patients were excluded from the study if they had menstrual irregularities or if the solitary benign lesion turned out to be a manifestation of a more serious breast condition. Altogether 122 patients were involved, 33 of whom had been taking oral contraceptives and 33 were parous. Mitotic indices and apoptotic indices were obtained on 113 and tritiated thymidine labelling studies were conducted on 101 biopsies.
Tissue samples Apart from the discreet solitary lesion the patients had otherwise palpably normal beasts. At surgery only grossly normal tissue was sampled. This was taken at a distance of at least 1 cm from the site of a fibroadenoma in 114, from the axillary tail during biopsies of lymph modes in 2 and during reduction mammoplasty in 6 patients.
Fresh (Ferguson & Anderson, 1981b (Meyer, 1977; Ferguson & Anderson, 1981a; Anderson et al., 1982; Going et al., 1988) .
These transforms are purely empirical in nature, being introduced to improve the validity of the statistical analysis.
They have no biological significance.
(c) Treatment of the menstrual cycle effects The cycle lengths reported by the patients varied. The data were therefore fitted to a day of cycle normalised to a standard cycle length of 28 days.
The simplest mathematical function describing such periodic behaviour is the single sinusoid.
where D is the day of cycle, L the cycle length and A and B constants. This is the first term in a Fourier series describing in full the periodic function, however there are insufficient data to merit going beyond this first term. Terms such as (1) were included in the regression equation, and the constants A and B fitted.
As alternatives, the data were fitted using categorical variables describing either the week of the cycle or the cycle half (i.e. 1st half or 2nd half).
These alternatives avoid any assumptions about the functional form of the periodic behaviour.
(d) Treatment of age effects Variables consisting of either the chronological age in years, or the estimated number of cycles since menarche were added to the regression equation.
(e) Other effects Other variables considered as candidates for the regression models were categorical variables for on/ off the pill and parous/non-parous, and a number of interaction terms including those between age and cycle, pill and cycle and age and pill. 
Results
The mean age of the 122 patients was 25.8 + 7.8 (s.d.) years with a range of 14 to 48 years. The average length of their menstrual cycles was 27.7+1.76 days with a range of 21 to 35 days (Table I) .
The range of values for the total number of epithelial cells per breast lobule was 32 to 285 based on 74 samples. The number of cells per lobule was unrelated to the age of the patient or the day of the menstrual cycle (Figure 2 ), or to any other of the parameters tested (see Materials and methods) .
The LI was measured in 101 samples and related significantly to both age of the patient and to the phase of the menstrual cycle in which the biopsy was taken. The change in LI during the menstrual cycle was cyclic with a peak value on 20.8 days and a minimum value at 6.8 days (Figure 3a) . Because the LI also changed with age the values were normalised to age 25 and the predicted best fit curve is shown as a solid line in Figure 3a ; the predicted best fit curve for women aged 15 is shown as the upper dashed line and for women aged 35 as the lower dashed line. No significant effect of contraceptive pill or of parity on the LI was observed. The square root of the LI declined significantly with age by 0.22 + 0.8% per decade ( Figure 3b ). Thus, for example, at age 25 the LI declines by 0.7% per decade, that is by 44% of the fitted mean value (LI= 1.54%) over the whole menstrual cycle at that age per decade. The estimated effect of the menstrual cycle is illustrated by the two lines in Figure 3b which represent the fitted regression lines for patients at the 7th and 21st days of the cycle.
The regression on age and the cycle effects only account for about 25% of the variability in the LI data. After taking This was confirmed in a second identical experiment.
The MI was meaasured in 113 samples and was also significantly influenced by age and the day of the menstrual cycle (Figure 4) . The square root of the MI declined by 0.072+0.027% per decade. Thus at age 25 the MI declines by 0.05% per decade, that is by 14% of the fitted mean value (MI=0.35%) at that age.
The MI values are at their highest on day 21.5 and lowest on day 7.5 of the cycle. No significant effect of the cycle on the apoptotic index (measured in 113 samples) could be detected but there was a significant decline with age ( Figure 5 ). The fitted square root of the AI of parous patients (n=30) was 0.16+0.07 greater than that of nonparous patients (n=83, P=0.03). The fitted variables in the regression curves for both the square root of the MI and Al account only for -10% of the variation in the data. Upper series young (<25y) and old (>25y) patients at weekly intervals throughout the menstrual cycle. Lower series the first and second halves of the cycle compared for different aged patients. Standard errors are shown. The total number of patients analysed here (numbers within the bars) is less than shown in Table I because the menstrual cycle data was inadequate for some patients. The data as a whole can be summarized by the values shown in Table I and the labelling index data, which show the effects most dramatically, by the bar diagrams in Figure  6 which shows the changes through the menstrual cycle and the influence of age. Both the increase in LI towards the end of the cycle and the decline in LI with age can be seen. (Ferguson & Anderson, 1981a) , chose mainly to use histologically normal tissue away from the site of fibroadenomas since these lesions are usually well circumscribed in mainly otherwise normal breasts. The LI data described here tend as a group to be slightly higher than the data of Flaxman and Lasfargues (1973) , Meyer (1977) , Masters et al. (1977) and Russo et al. (1987) .
The mean apoptotic index is also slightly higher than that presented by Ferguson & Anderson (1981a) . However, the range of LI and Al values is similar. The reasons for these differences are not clear but could be related to differences in technique or of patient populations. We could see little evidence of the dampening effect of age on menstrual cycle changes in Al ( Figure 5 ) that were reported by Anderson et al. (1982) . However, our Al data were not significantly influenced by the menstrual cycle, i.e., were already very dampened (see Figure 5) .
The validity of short term in vitro labelling studies can be questioned. The main area of doubt is whether or not 3HTdR effectively penetrates to all levels within the 1 mm thick slice of tissue. In order to partially overcome this potential problem previous workers have either employed increased levels of oxygenation or a complex process of lobular dissection, neither of which we believe is necessary. This is borne out by the fact that our LI values on the whole are higher than previously published values and that labell- However, the length of S has been calculated to be 8.1 h from double labelling studies (Russo et al., 1987) in which case the labelling and mitotic data would suggest that the duration of M in the breast is 30 min.
Although we believe that a one hour incubation at 37°C in a medium containing 3HTdR is a reliable means of obtaining a flash labelling index there is some doubt as to whether cells continue to enter S or M at a normal rate in the short term cultures. Two previous studies (Flaxman & Lasfargues, 1973; Masters et al., 1977 ) employed a 4h labelling protocol but there is little evidence that this results in an elevated LI (TableII) compared with the flash labelling index which is confirmed by preliminary short term continuous incubations in 3HTdR in our laboratory. This throws some doubt on the validity of double labelling or continuous labelling studies (Russo et al., 1987) . Some data suggest that mitosis and particularly entry into mitosis is a sensitive process that is disrupted by surgical procedures and short term culturing (Potten, 1987) . For this reason we believe that mitotic counts should be conducted on tissue fixed rapidly after excision and not on the material incubated in 3HTdR. In our studies this was generally achieved within 10 minutes of surgery.
Assuming a Ts value of 8.1 h for intralobular epithelial cells (Russo et al., 1987) , and bearing in mind the preceding comments, the LI data presented here could be taken to indicate an upper limit for the turnover time of 308h for human breast. However, the value of such a calculation is questionable for a number of reasons: (a) this assumes that all epithelial cells are involved in cell proliferation which is unlikely. Russo et al., (1987) estimated, using continuous labelling in vitro (see criticisms above), that the growth fraction might be 0.32 in which case the cell cycle time could be about 100 h; (b) it is questionable whether such a calculation which assumes a steady state can be applied to a system which is clearly cyclic in its proliferation (c) the value of Ts must remain somewhat uncertain for this system (see criticisms above); (d) little is known about the age distribution which influences this calculation. A rectangular distribution has been assumed but may not be valid.
There Meyer (1977) , Anderson et al., (1982) and Russo et al. (1987) . Leung et al., 1981;  McManus & Welsche, 1984; Horwitz & Freidenberg, 1985; Mauvais-Jarvis et al., 1986 , Braunsberg et al., 1986 Hissom & Moore, 1987; Longman and Beuhring, 1987 (Murphy et al., 1986a, b) . A recent report of increased incidence of breast cancer after prolonged use of the high dose progesterone oral contraceptives may be important in this context (Pike et al., 1983). However, in the present study and those of Meyer (1977) and Anderson et al., (1982) there were no apparent differences in the proliferative indices between women taking oral contraceptives and those not. In fact in the present study we could detect no significant difference between the pill users (n = 33) and the non-pill users (n = 89) for any parameter measured after both age and stage of the menstrual cycle were taken into account.
Epidemiological studies have shown recently that in contradistinction to the 'oestrogen window' hypothesis of Korenman (1980) the early occurrence of regular (and thus probably ovular) menstrual cycles is associated with a increased risk of breast cancer (Henderson et al., 1985 , La Vecchia et al., 1985 . Regular cycles are likely to be ovular and thus progesterone would be expected to be secreted by the corpus luteum. The association between progesterone synthesis and risk is consistent with the finding in the study reported here where the increased index is found in the same phase of the cycle as maximum progesterone levels.
Studies on the factors that increase the risk of developing breast cancer suggest that risk increases in situations where the number of non-reproductive ovular menstrual cycles are greatest, i.e. the more times the breast is subjected to the few rounds of cell division that prepare the breast for the more severe proliferative and differentiative changes required in pregnancy, the greater is the risk of cancer. In contrast the changes involved in pregnancy diminish the risk of breast cancer if they occur early in life. The reduction in the total number of menstrual cycles that would occur at each pregnancy is not sufficient to account for this protection, which is more likely to be due to some changes in the proliferative/differentiative status of the breast. An early pregnancy must in some way change the number, or susceptibility, of carcinogenic target cells in the breast. However, we could detect no differences in the parameters examined between the parous and non-parous patients. One possibility is that the breast of a parous woman contains a different balance of stem and differentiated transitory proliferative cells. It is possible that with successive menstrual cycles after parity the changes in the breast preparative to further pregnancies are adequately accommodated by a greater proliferative contribution from differentiated cells rather than stem cells and the latter may play a much greater role in carcinogenesis.
Whether or not any of the indices measured here might prove to be predictive for the patients (approximately 10) expected to develop cancer remains to be seen. Although a general abnormally high proliferative activity throughout the breast may predispose the tissue to malignant transformation cancers may originate from one or a few isolated cells with abnormal proliferative/differentiative behaviour within a pool of cells behaving normally. One point that remains unclear is whether or not a patient with a high LI value after age and stage of cycle have been taken into account, has a generally elevated proliferative activity or has merely been sampled by chance at the time of peak proliferative activity for that menstrual cycle. In other words, it is unclear whether the proliferative changes through the cycle for an individual are best described by a broad peak in the later part of the cycle or by a sharp discrete peak, or step up, in proliferative activity. The variability observed here and in the other studies then may be the consequence of either differences in absolute levels of proliferation between patients or it may be the consequence of a wide range of differences in the timing of the discrete peaks in proliferative activity between patients which may reflect differences between patients in the timing of their hormonal stimuli, i.e. patients may differ in the total amount of proliferation that occurs each cycle or they may all have about the same amount of proliferation but differ in the time in the cycle when they undertake this proliferation.
